Ii Robert C. Goeltz Arcus Biosciences, Inc. (RCUS) insider trading activity
Ii Robert C. Goeltz is Chief Financial Officer of Arcus Biosciences, Inc.. Currently has a direct ownership of 97,138 shares of RCUS, which is worth approximately $1.3 Million. The most recent transaction as insider was on Jan 23, 2025, when has been sold 37,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
97.1K
32.83%
3M change
32.83%
12M change
Total Value Held
$1.3 Million
II Robert C. Goeltz Transaction History
IRC
Ii Robert C. Goeltz
Chief Financial Officer
Hayward, CA